A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70318 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Lijun Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics and Center for Rare Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejia…. Hauptthemen laut MEDLINE: Myopathies, Structural, Congenital, Protein Tyrosine Phosphatases, Non-Receptor, Frameshift Mutation. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Key Research and Development Program of Zhejiang Province.
Abstract (Originalsprache)
Background
MTM1 ‐related X‐linked myotubular myopathy (XLMTM) typically affects males; however, symptomatic female carriers may occur.
Methods
We evaluated a 24‐year‐old woman with infantile hypotonia followed by slowly progressive, asymmetric proximal weakness with facial and ocular involvement. Clinical assessment, pulmonary function testing, electromyography, lower‐limb muscle MRI, and muscle biopsy were performed. Next‐generation sequencing and parental segregation analysis were conducted.
Results
The patient developed progressive functional decline leading to wheelchair dependence. Investigations showed moderate‐to‐severe restrictive ventilatory impairment, a myopathic pattern on electromyography, and extensive fatty replacement on muscle MRI. Muscle biopsy demonstrated histopathological features consistent with centronuclear myopathy. Genetic testing identified a heterozygous MTM1 insertion, c.1266_1267insATGGTGATAAAAACCATTCA, predicted to cause a frameshift (p.Gly423MetfsTer48). The variant was absent in both parents, supporting a de novo event. To our knowledge, this MTM1 variant has not been previously reported.
Conclusion
This case expands the MTM1 variant spectrum and highlights that de novo MTM1 frameshift variants can underlie clinically significant XLMTM manifestations in females, underscoring the value of genetic testing in symptomatic women with centronuclear myopathy features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics and Center for Rare Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Nursing, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
ORCID-Profile: Lijun Chen, Gonglu Liu
Förderung
- Natural Science Foundation of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
Zitieren
APA
Chen, L., Bao, Y., & Liu, G. (2026). A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70318
Vancouver
Chen L, Bao Y, Liu G. A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70318
BibTeX
@article{Chen2026,
author = {Chen, Lijun and Bao, Yingxiao and Liu, Gonglu},
title = {A Novel De Novo MTM1 Insertion Frameshift Variant Causes X‐Linked Myotubular Myopathy in a Chinese Female},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70318}
}
EUVIMED